Aditxt

ADTX · NASDAQ

$0.0008−$0.0002 (−20.00%)TodayMarket closed ·
Prev close $0.001

Latest news

  • NewsTanya Rawat

    Aditxt (ADTX) Stock Sinks 20% After-Hours: Here’s What’s Going On

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Monday's Intraday Session

  • NewsAvi Kapoor

    Nasdaq Surges 300 Points; US Initial Jobless Claims Edge Lower

  • NewsAvi Kapoor

    Why Smith & Wesson Brands Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • NewsAvi Kapoor

    Crude Oil Edges Higher; US Retail Sales Top Estimates

  • NewsAvi Kapoor

    US Stocks Edge Higher; CarMax Posts Upbeat Earnings

  • NewsTanya Rawat

    Aditxt (ADTX) Stock Is Falling After Hours: What Is Going On?

  • NewsMohd Haider

    Aditxt (ADTX) Stock Surges Nearly 17% After Hours: Here's Why

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • NewsLekha Gupta

    What's Going On With Aditxt Stock Wednesday?

  • News

    Aditxt Unit Ignite Proteomics To Merge With A Strategic Counterparty At An Implied Equity Valuation Of ~$150M

  • Press releaseBusiness Wire

    Aditxt Signed Definitive Agreement Valuing Ignite Proteomics at Approximately $150 Million

  • Press releaseBusiness Wire

    Ignite Proteomics Announces Prospective 10,000-Patient Oncology Registry to Evaluate Functional Proteomics in Cancer Therapy Selection

  • NewsAvi Kapoor

    Why Hewlett Packard Enterprise Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket

  • Press releaseBusiness Wire

    Aditxt, Inc. Appoints Jeffrey M. Busch as Interim Chief Executive Officer; Founder and Former CEO of $1B NYSE Enterprise Which Delivered ~8.5% Dividends to Shareholders

  • News

    12 Health Care Stocks Moving In Friday's After-Market Session

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • NewsAvi Kapoor

    Nasdaq Surges Over 1%; Chicago Fed National Activity Index Rises In April

  • NewsAvi Kapoor

    Dow Jumps 250 Points; BJ's Wholesale Shares Fall After Q1 Results

  • NewsAvi Kapoor

    Nasdaq Down 200 Points; Brady Earnings Top Views

  • Press releaseBusiness Wire

    Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-27 Reverse Stock Split Effective at the Open of Trading on May 18, 2026

  • News

    12 Health Care Stocks Moving In Monday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • Press releaseBusiness Wire

    Dana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics' RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patients

  • Press releaseBusiness Wire

    Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer

  • Press releaseBusiness Wire

    Aditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection

  • Press releaseBusiness Wire

    Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-8 Reverse Stock Split Effective at the Open of Trading on March 9, 2026

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • NewsAvi Kapoor

    Dow Jumps 150 Points; Jabil Posts Upbeat Earnings

  • NewsRishabh Mishra

    Stock Market Today: S&P 500, Dow Futures Gain As Jobs Data Weighs On Outlook—Lennar, Micron Technology, Children's Place In Focus (UPDATED)

  • NewsAvi Kapoor

    Why Vision Marine Technologies Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

  • News

    12 Health Care Stocks Moving In Monday's After-Market Session

  • Press releaseBusiness Wire

    Aditxt Provides Updates on its Growth Vision for bitXbio™, Planned Digital Asset Treasury, Pearsanta's Planned IPO, And Evofem's Plan to Regain a National Listing

  • NewsAvi Kapoor

    Nasdaq Falls Over 1%; Alphabet Posts Upbeat Earnings

  • Press releaseBusiness Wire

    Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-113 Reverse Stock Split Effective at the Open of Trading on November 3, 2025

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • Press releasePRNewswire

    Evofem Announces Voting Results from Special Meeting of Stockholders

  • Press releasePRNewswire

    Evofem Reports Positive Financial Results for Second Quarter of 2025, Provides Business Update

  • Press releaseBusiness Wire

    Aditxt and Crypto.com Sign Agreement for Custodial Crypto Account, Announce ADTX Share Access on Crypto.com as Part of the Larger bitXbio™ Initiative

  • Press releaseGlobe Newswire

    Appili Therapeutics Provides Update on Arrangement with Aditxt, Inc.

  • Press releaseBusiness Wire

    Aditxt Subsidiary Adimune Announces Positive Results from Mayo Clinic Pre-Clinical Studies to Support FDA and European Regulatory Submissions for Type 1 Diabetes, Psoriasis, and Stiff Person Syndrome Human Trials

  • Press releaseGlobe Newswire

    Appili President and CEO, Don Cilla to Join Aditxt CEO, Amro Albanna for Aditxt Weekly Update on April 4, 2025

  • Press releasePRNewswire

    Evofem Reports Fourth Consecutive Year of Net Sales Growth

  • Press releasePRNewswire

    Evofem Biosciences Announces Financial Results for the Third Quarter of 2024

  • NewsAvi Kapoor

    Why Granite Point Mortgage Trust Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

  • Press releasePRNewswire

    Evofem Biosciences Announces Financial Results for the Second Quarter of 2024

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.